Oxidative Medicine and Cellular Longevity

Oxidative Medicine and Cellular Longevity / 2017 / Article

Corrigendum | Open Access

Volume 2017 |Article ID 9483845 | 1 page | https://doi.org/10.1155/2017/9483845

Corrigendum to “(−)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats”

Received05 Apr 2017
Accepted10 Apr 2017
Published16 May 2017

In the article titled “(−)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats” [1], there was an error in the section “2.1. Animals and Treatment,” where the sentence “Concentrated Epi solution (100 mg/mL) was prepared fresh every day before administration to rats by dilution of Epi in tap water (85°C, 3 min, in water bath)” should be corrected to “Concentrated Epi solution (10 mg/mL) was prepared fresh every day before administration to rats by dilution of Epi in tap water (85°C, 3 min, in water bath).”

References

  1. M. Kluknavsky, P. Balis, A. Puzserova et al., “(−)-Epicatechin Prevents Blood Pressure Increase and Reduces Locomotor Hyperactivity in Young Spontaneously Hypertensive Rats,” Oxidative Medicine and Cellular Longevity, vol. 2016, Article ID 6949020, p. 14, 2016. View at: Publisher Site | Google Scholar

Copyright © 2017 M. Kluknavsky et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

450 Views | 189 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.